Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon-γ-Dependent Manner

Cancer Immunology Research
Moritz F EissmannFrederick Masson

Abstract

Interleukin 33 (IL33) is an inflammatory cytokine released during necrotic cell death. The epithelium and stroma of the intestine express large amounts of IL33 and its receptor St2. IL33 is therefore continuously released during homeostatic turnover of the intestinal mucosa. Although IL33 can prevent colon cancer associated with inflammatory colitis, the contribution of IL33 signaling to sporadic colon cancer remains unknown. Here, we utilized a mouse model of sporadic colon cancer to investigate the contribution of IL33 signaling to tumorigenesis in the absence of preexisting inflammation. We demonstrated that genetic ablation of St2 enhanced colon tumor development. Conversely, administration of recombinant IL33 reduced growth of colon cancer cell allografts. In reciprocal bone marrow chimeras, the concurrent loss of IL33 signaling within radioresistant nonhematopoietic, and the radiosensitive hematopoietic, compartments was associated with increased tumor burden. We detected St2 expression within the radioresistant mesenchymal cell compartment of the colon whose stimulation with IL33 induced expression of bona fide NF-κB target genes. Mechanistically, we discovered that St2 deficiency within the nonhematopoietic compartment ...Continue Reading

References

Mar 23, 2000·The Journal of Experimental Medicine·M J TownsendA N McKenzie
Dec 7, 2005·International Journal of Cancer. Journal International Du Cancer·Emi OsawaTaeko Dohi
Aug 7, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alissa A ChackerianRobert A Kastelein
Mar 7, 2009·European Journal of Immunology·Elvire BourgeoisAndré Herbelin
Jan 19, 2010·Nature Reviews. Immunology·Foo Y LiewIain B McInnes
Apr 14, 2010·Proceedings of the National Academy of Sciences of the United States of America·Luca PastorelliTheresa T Pizarro
May 19, 2010·Cell Division·Andrew JarnickiMatthias Ernst
Jun 7, 2011·Digestive Diseases and Sciences·Pinghu SunYunlin Wu
Sep 3, 2011·European Journal of Immunology·Qianting YangBinfeng Lu
Feb 11, 2012·Science·Weldy V BonillaDaniel D Pinschewer
May 21, 2013·Nature Immunology·Paula Licona-LimónRichard A Flavell
Oct 25, 2013·Nature Reviews. Cancer·Eran ElinavRichard A Flavell
Apr 12, 2014·Blood·Frederick MassonGabrielle T Belz
Jul 2, 2014·Proceedings of the National Academy of Sciences of the United States of America·Jun-Xia WangPeter A Nigrovic
Jul 22, 2014·Nature·Chris SchieringFiona Powrie
Oct 18, 2014·Cancer Immunology, Immunotherapy : CII·Guanglin CuiJon Florholmen
Nov 11, 2014·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Lu WangXianjun Qu
Nov 28, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xin GaoBinfeng Lu
Apr 2, 2015·Proceedings of the National Academy of Sciences of the United States of America·Claudia BaumannMax Löhning
Apr 29, 2015·Proceedings of the National Academy of Sciences of the United States of America·Rebecca L MaywaldJason D Heaney
May 1, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tsukasa NabekuraLewis L Lanier
Jun 18, 2015·Immunity·Ari B MolofskyRichard M Locksley
Dec 2, 2015·The Journal of Experimental Medicine·Charles K PallangyoFlorian R Greten
Dec 19, 2015·British Journal of Cancer·Charlotte O'DonnellAileen Houston
Dec 22, 2015·Immunobiology·Mousa Komai-KomaDamo Xu
Jan 20, 2016·Nature Immunology·Nikolas T Martin, Michael U Martin
Mar 5, 2016·Oncoimmunology·Kirsten D MertzPhilippe Krebs
Apr 9, 2016·Trends in Immunology·Michael PeineMax Löhning
May 31, 2016·World Journal of Gastroenterology : WJG·Jordan E AxelradVijay Yajnik
Jun 28, 2016·Oncology Letters·Dorothee GramatzkiKirsten Diana Mertz
Oct 25, 2016·The Journal of Clinical Investigation·Ankit MalikThirumala-Devi Kanneganti

❮ Previous
Next ❯

Citations

Sep 13, 2018·International Journal of Molecular Sciences·Kristen M LarsenMaria Marjorette O Peña
Apr 10, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Jiguang ZhangXing Lin
Jul 29, 2020·Frontiers in Immunology·Moritz F EissmannMatthias Ernst
Jul 25, 2018·Cancer Medicine·Ling Ni, Jian Lu
Nov 9, 2018·Frontiers in Immunology·Ourania S KotsiouSotirios G Zarogiannis
Nov 30, 2018·Frontiers in Immunology·Claudia AfferniGiovanna Schiavoni
Sep 15, 2020·Oncoimmunology·Melanie KienzlRudolf Schicho
Nov 13, 2018·Frontiers in Immunology·Jean-Jacques Fournié, Mary Poupot
Jan 9, 2019·Frontiers in Immunology·Jia-Xin ShenGuo-Jun Zhang
Jun 23, 2019·Nature Communications·Moritz F EissmannMatthias Ernst
Jan 1, 2020·Journal of Bone Oncology·Qingxi LinShoufeng Wang
Jun 21, 2020·Current Cancer Drug Targets·Yue WangHairui Wang
Jun 3, 2021·International Journal of Molecular Sciences·Laura Francesca PisaniLuca Pastorelli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Rebecca L MaywaldJason D Heaney
Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte
Binfeng LuQingqing Wang
Ai zheng = Aizheng = Chinese journal of cancer
Hua-Yi Wang, Zhao-Xiang Zhang
© 2022 Meta ULC. All rights reserved